Page 3«..2345..1020..»

Food Nanotechnology Market Key Player, Regions, Manufacturers Analysis, Application and Specification, Cost Analysis, Price and Gross Margin by…

§ January 5th, 2021 § Filed under Nanotech Comments Off on Food Nanotechnology Market Key Player, Regions, Manufacturers Analysis, Application and Specification, Cost Analysis, Price and Gross Margin by…

Global Food Nanotechnology Market Report available at In4Research provides a roadmap of the Food Nanotechnology industry which makes up for the scope of product, market revenue cycle, new opportunities, CAGR, sales volumes, and figures. The demand for Food Nanotechnology is expected to grow significantly as the industry becomes increasingly popular. The two major factors examined in this report include market revenue and market size.

The Food Nanotechnology market study is an in-depth analysis of this industry that effectively covers all the aspects related to this industry over the projected period and the primary development trends of the market, over the forecast period (2020-2026). This report on the global Food Nanotechnology market is designed to serve as a ready-to-use guide for developing accurate pandemic management programs allowing market players to successfully emerge from the crisis and retract numerous gains and profits.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of Food Nanotechnology market report at:

Competitive Landscape:

A lot of companies are trying to make the market for the global Food Nanotechnology prosper with high growth opportunities. These segments are known for extensive participation in taking the market ahead. In4Research recorded their recent steps to gauge in which direction the market is moving and find better growth possibilities there.

The Food Nanotechnology Market Report Covers Major Players:

Food Nanotechnology Market Segmentation:

The global market for Food Nanotechnology is set to find a segmentation in the report that would be based on type, and application. These segments have a better acceptance of various factors that can be taken into consideration to understand how the market can chart the future path.

Food Nanotechnology Market Breakdown by type

Food Nanotechnology Market Breakdown by Application

Get the PDF to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies:

Regional Analysis Covered in Food Nanotechnology Report are:

Key Highlights of the Table of Contents:

Food Nanotechnology Market Study Coverage: It includes key market segments, key manufacturers covered, the scope of products offered in the years considered, global Food Nanotechnology Market and study objectives. Additionally, it touches the segmentation study provided in the report on the basis of the type of product and applications.

Food Nanotechnology Market Executive summary: This section emphasizes the key studies, market growth rate, competitive landscape, market drivers, trends, and issues in addition to the macroscopic indicators.

Food Nanotechnology Market Production by Region: The report delivers data related to import and export, revenue, production, and key players of all regional markets studied are covered in this section.

Food Nanotechnology Market Profile of Manufacturers: Analysis of each market player profiled is detailed in this section. This segment also provides SWOT analysis, products, production, value, capacity, and other vital factors of the individual player.

Enquire More About Food Nanotechnology Market Research at

In this study, the years considered to estimate the market size of Food Nanotechnology Market:

History Year: 2015 2020

Base Year: 2020

Estimated Year: 2021

Forecast Year: 2021 2026

Reasons you should buy this report:

To Buy Full Report, Connect with us at:

For more Details Contact Us:

Contact Name: Rohan

Email: [emailprotected]

Phone: +1 (407) 768-2028

Read more from the original source:

Food Nanotechnology Market Key Player, Regions, Manufacturers Analysis, Application and Specification, Cost Analysis, Price and Gross Margin by...

Read the Rest...

Air pollution may contribute to Alzheimers and dementia risk here’s what we’re learning from brain scans – The Conversation US

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on Air pollution may contribute to Alzheimers and dementia risk here’s what we’re learning from brain scans – The Conversation US

Alzheimers disease is the most common cause of dementia. It slowly destroys memory, thinking and behaviors, and eventually the ability to carry out daily tasks.

As scientists search for a cure, we have been learning more about the genetic and environmental factors that can increase a persons risks of developing late-onset Alzheimers disease and related dementias.

In particular, my colleagues and I in preventive medicine, neurology and gerontology have been looking at the role of outdoor air pollution.

Our early research in 2017 became the first study in the U.S. using both human and animal data to show that brain aging processes worsened by air pollution may increase dementia risk. Our latest studies show how older women who lived in locations with high levels of PM2.5 the fine particulate matter produced by vehicles and power plants suffered memory loss and Alzheimers-like brain shrinkage not seen in women living with cleaner air.

Together these findings suggest a way to avoid one risk factor for Alzheimers disease reduce human exposure to PM2.5. Unfortunately, thats easier said than done.

PM2.5, also known as soot, consists of microscopic particles of chemicals, car exhaust, smoke, dust and other pollutants suspended in the air. An estimated one in six Americans lives in counties with unhealthy levels of particle pollution.

We have been investigating whether PM2.5 may accelerate the brains aging processes at the preclinical stage the silent phase of the disease before any symptoms of Alzheimers disease and related dementias appear.

In the first U.S.-based nationwide study to link PM2.5 exposure and cognitive impairment, published in 2017, we found older women were almost twice as likely to develop clinically significant cognitive impairment if they had lived in places with outdoor PM2.5 levels exceeding the U.S. Environmental Protection Agencys standard than if they hadnt. Because we worked with the Womens Health Initiative Memory Study, which followed the participants closely, we were able to account for other dementia risk factors, such as smoking, lack of exercise and hormone therapy.

In a new study, we wanted to see how the brains of older people were changing if they had experienced different levels of PM2.5 in the years before Alzheimers symptoms began.

We followed the progress of 712 women with an average age of 78 who did not have dementia at the start of the study and who underwent MRI brain scans five years apart. By combining EPA monitoring data and air quality simulations, we were able to estimate the everyday outdoor PM2.5 level around where the participants lived before their first MRI scan.

We found older women were more likely to have brain shrinkage similar to what is observed in patients with Alzheimers disease. When we compared the brain scans of older women from locations with high levels of PM2.5 to those with low levels, we found dementia risk increased by 24% over the five years.

Perhaps more alarming is that these Alzheimers-like brain changes were present in older women with no memory problems. The shrinkage in their brains was greater if they lived in locations with higher levels of outdoor PM2.5, even when those levels were within the current EPA standard.

Researchers in Spain recently examined brain MRI scans of healthy individuals at risk for Alzheimers disease and also found associations between air pollution exposure and reduced volume and thickness in specific brain areas known to be affected in Alzheimers disease.

We also looked at episodic memory, which involves memories of specific events and is affected early by Alzheimers disease. If episodic memory decline was associated with living in locations with increasing PM2.5, could we see any evidence that such specific cognitive decline came as a consequence of the Alzheimers-like brain shrinkage?

Data from the Womens Health Initiative Memory Study and past MRIs allowed us to look for changes across time for nearly 1,000 women. We found that as outdoor PM2.5 increased in locations where these older women lived, episodic memory declined. Approximately 10%-20% of the greater memory decline could be explained by Alzheimers-like brain shrinkage.

[Deep knowledge, daily. Sign up for The Conversations newsletter.]

Because the silent phase of dementia is thought to start decades before the manifestation of symptoms, findings from our recent studies raise concerns that air pollution exposures during mid to early life may be equally or even more important than late-life exposure.

Genes also appear to play a role. Our research has shown that a critical Alzheimers risk gene, APOE4, interacts with air particles to accelerate brain aging. We found the environmental risk raised by long-term PM2.5 exposure was two to three times higher among older women with two copies of the APOE4 gene than among women without the gene.

Other researchers have subsequently investigated the possible interplay of that gene and environment. A Swedish study in 2019 did not find strong evidence for gene and environment interaction. But a 2020 study using data collected from elderly residents of two New York City neighborhoods found an association between long-term air pollution exposure and cognitive decline, with steeper rates of decline found in APOE4 carriers.

In the U.S., the Clean Air Act requires the Environmental Protection Agency to develop air quality standards that provide an adequate margin of safety to protect sensitive populations, such as children and the elderly.

The U.S. government had an opportunity to strengthen those standards in 2020, a move that EPA scientists explained could prevent thousands of premature deaths from health risks such as heart disease. Scientists advocated tougher standards, citing other health problems linked to PM2.5. However, EPA Administrator Andrew Wheeler declined, announcing on Dec. 7 that the standards would remain unchanged.

Read this article:
Air pollution may contribute to Alzheimers and dementia risk here's what we're learning from brain scans - The Conversation US

Read the Rest...

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 – – HIT Consultant

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 – – HIT Consultant

As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021.

Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare

Federated Learning:The clinical community will increase their use offederated learning approachesto build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models built at a single institution, even when there is copious data to train with. As an added bonus, researchers can collaborate on AI model creation without sharing confidential patient information. Federated learning is also beneficial for building AI models for areas where data is scarce, such as for pediatrics and rare diseases.

AI-Driven Drug Discovery:The COVID-19 pandemic has put a spotlight ondrug discovery, which encompasses microscopic viewing of molecules and proteins, sorting through millions of chemical structures, in-silico methods for screening, protein-ligand interactions, genomic analysis, and assimilating data from structured and unstructured sources. Drug development typically takes over 10 years, however, in the wake of COVID, pharmaceutical companies, biotechs, and researchers realize that acceleration of traditional methods is paramount. Newly created AI-powered discovery labs with GPU-accelerated instruments and AI models will expedite time to insight creating a computing time machine.

Smart Hospitals: The need for smart hospitals has never been more urgent. Similar to the experience at home, smart speakers and smart cameras help automate and inform activities. The technology, when used in hospitals, will help scale the work of nurses on the front lines, increase operational efficiency, and provide virtual patient monitoring to predict and prevent adverse patient events.

Omri Shor, CEO of Medisafe

Healthcare policy: Expect to see more moves on prescription drug prices, either through a collaborative effort among pharma groups or through importation efforts. Pre-existing conditions will still be covered for the 135 million Americans with pre-existing conditions.

The Biden administration has made this a central element of this platform, so coverage will remain for those covered under ACA. Look for expansion or revisions of the current ACA to be proposed, but stalled in Congress, so existing law will remain largely unchanged. Early feedback indicates the Supreme Court is unlikely to strike down the law entirely, providing relief to many during a pandemic.

Brent D. Lang, Chairman & Chief Executive Officer, Vocera Communications

The safety and well-being of healthcare workers will be a top priority in 2021. While there are promising headlines about coronavirus vaccines, we can be sure that nurses, doctors, and other care team members will still be on the frontlines fighting COVID-19 for many more months. We must focus on protecting and connecting these essential workers now and beyond the pandemic.

Modernized PPE Standards Clinicians should not risk contamination to communicate with colleagues. Yet, this simple act can be risky without the right tools. To minimize exposure to infectious diseases, more hospitals will rethink personal protective equipment (PPE) and modernize standards to include hands-free communication technology. In addition to protecting people, hands-free communication can save valuable time and resources. Every time a nurse must leave an isolation room to answer a call, ask a question, or get supplies, he or she must remove PPE and don a fresh set to re-enter. With voice-controlled devices worn under PPE, the nurse can communicate without disrupting care or leaving the patients bedside.

Improved Capacity

Voice-controlled solutions can also help new or reassigned care team members who are unfamiliar with personnel, processes, or the location of supplies. Instead of worrying about knowing names or numbers, they can use simple voice commands to connect to the right person, group, or information quickly and safely. In addition to simplifying clinical workflows, an intelligent communication system can streamline operational efficiencies, improve triage and throughput, and increase capacity, which is all essential to hospitals seeking ways to recover from 2020 losses and accelerate growth.

Michael Byczkowski, Global Vice President, Head of Healthcare Industry at SAP,

New, targeted healthcare networks will collaborate and innovate to improve patient outcomes.

We will see many more touchpoints between different entities ranging from healthcare providers and life sciences companies to technology providers and other suppliers, fostering a sense of community within the healthcare industry. More organizations will collaborate based on existing data assets, perform analysis jointly, and begin adding innovative, data-driven software enhancements. With these networks positively influencing the efficacy of treatments while automatically managing adherence to local laws and regulations regarding data use and privacy, they are paving the way for software-defined healthcare.

Smart hospitals will create actionable insights for the entire organization out of existing data and information.

Medical records as well as operational data within a hospital will continue to be digitized and will be combined with experience data, third-party information, and data from non-traditional sources such as wearables and other Internet of Things devices. Hospitals that have embraced digital are leveraging their data to automate tasks and processes as well as enable decision support for their medical and administrative staff. In the near future, hospitals could add intelligence into their enterprise environments so they can use data to improve internal operations and reduce overhead.

Curt Medeiros, President and Chief Operating Officer of Ontrak

As health care costs continue to rise dramatically given the pandemic and its projected aftermath, I see a growing and critical sophistication in healthcare analytics taking root more broadly than ever before. Effective value-based care and network management depend on the ability of health plans and providers to understand what works, why, and where best to allocate resources to improve outcomes and lower costs. Tied to the need for better analytics, I see a tipping point approaching for finally achieving better data security and interoperability. Without the ability to securely share data, our industry is trying to solve the worlds health challenges with one hand tied behind our backs.

G. Cameron Deemer, President, DrFirst

Like many business issues, the question of whether to use single-vendor solutions or a best-of-breed approach swings back and forth in the healthcare space over time. Looking forward, the pace of technology change is likely to swing the pendulum to a new model: systems that are supplemental to the existing core platform. As healthcare IT matures, its often not a question of can my vendor provide this? but can my vendor provide this in the way I need it to maximize my business processes and revenues?

This will be more clear with an example: An EHR may provide a medication history function, for instance, but does it include every source of medication history available? Does it provide a medication history that is easily understood and acted upon by the provider? Does it provide a medication history that works properly with all downstream functions in the EHR? When a provider first experiences medication history during a patient encounter, it seems like magic.

After a short time, the magic fades to irritation as the incompleteness of the solution becomes more obvious. Much of the newer healthcare technologies suffer this same incompleteness. Supplementing the underlying systems capabilities with a strongly integrated third-party system is increasingly going to be the strategy of choice for providers.

Angie Franks, CEO of Central Logic

In 2021, we will see more health systems moving towards the goal of truly operating as one system of care. The pandemic has demonstrated in the starkest terms how crucial it is for health systems to have real-time visibility into available beds, providers, transport, and scarce resources such as ventilators and drugs, so patients with COVID-19 can receive the critical care they need without delay. The importance of fully aligning as a single integrated system that seamlessly shares data and resources with a centralized, real-time view of operations is a lesson that will resonate with many health systems.

Expect in 2021 for health systems to enhance their ability to orchestrate and navigate patient transitions across their facilities and through the continuum of care, including post-acute care. Ultimately, this efficient care access across all phases of care will help healthcare organizations regain revenue lost during the historic drop in elective care in 2020 due to COVID-19.

In addition to elevating revenue capture, improving system-wide orchestration and navigation will increase health systems bed availability and access for incoming patients, create more time for clinicians to operate at the top of their license, and reduce system leakage. This focus on creating an operating as one mindset will not only help health systems recover from 2020 losses, it will foster sustainable and long-term growth in 2021 and well into the future.

John Danaher, MD, President, Global Clinical Solutions, Elsevier

COVID-19 has brought renewed attention to healthcare inequities in the U.S., with the disproportionate impact on people of color and minority populations. Its no secret that there are indicative factors, such as socioeconomic level, education and literacy levels, and physical environments, that influence a patients health status. Understanding these social determinants of health (SDOH) better and unlocking this data on a wider scale is critical to the future of medicine as it allows us to connect vulnerable populations with interventions and services that can help improve treatment decisions and health outcomes. In 2021, I expect the health informatics industry to take a larger interest in developing technologies that provide these kinds of in-depth population health insights.

Jay Desai, CEO and co-founder of PatientPing

2021 will see an acceleration of care coordination across the continuum fueled by the Centers for Medicare and Medicaid Services (CMS) Interoperability and Patient Access rules e-notifications Condition of Participation (CoP), which goes into effect on May 1, 2021. The CoP requires all hospitals, psych hospitals, and critical access hospitals that have a certified electronic medical record system to provide notification of admit, discharge, and transfer, at both the emergency room and the inpatient setting, to the patients care team. Due to silos, both inside and outside of a providers organization, providers miss opportunities to best treat their patients simply due to lack of information on patients and their care events.

This especially impacts the most vulnerable patients, those that suffer from chronic conditions, comorbidities or mental illness, or patients with health disparities due to economic disadvantage or racial inequity. COVID-19 exacerbated the impact on these vulnerable populations. To solve for this, healthcare providers and organizations will continue to assess their care coordination strategies and expand their patient data interoperability initiatives in 2021, including becoming compliant with the e-notifications Condition of Participation.

Kuldeep Singh Rajput, CEO and founder of Biofourmis

Driven by CMS Acute Hospital at Home program announced in November 2020, we will begin to see more health systems delivering hospital-level care in the comfort of the patients homesupported by technologies such as clinical-grade wearables, remote patient monitoring, and artificial intelligence-based predictive analytics and machine learning.

A randomized controlled trial by Brigham Health published in Annals of Internal Medicine earlier this year demonstrated that when compared with usual hospital care, Home Hospital programs can reduce rehospitalizations by 70% while decreasing costs by nearly 40%. Other advantages of home hospital programs include a reduction in hospital-based staffing needs, increased capacity for those patients who do need inpatient care, decreased exposure to COVID-19 and other viruses such as influenza for patients and healthcare professionals, and improved patient and family member experience.

Jake Pyles, CEO, CipherHealth

The disappearance of the hospital monopoly will give rise to a new loyalty push

Healthcare consumerism was on the rise ahead of the pandemic, but the explosion of telehealth in 2020 has effectively eliminated the geographical constraints that moored patient populations to their local hospitals and providers. The fallout has come in the form of widespread network leakage and lost revenue. By October, in fact, revenue for hospitals in the U.S. was down 9.2% year-over-year. Able to select providers from the comfort of home and with an ever-increasing amount of personal health data at their convenience through the growing use of consumer-grade wearable devices, patients are more incentivized in 2021 to choose the provider that works for them.

After the pandemic fades, well see some retrenchment from telehealth, but it will remain a mainstream care delivery model for large swaths of the population. In fact, post-pandemic, we believe telehealth will standardize and constitute a full 30% to 40% of interactions.

That means that to compete, as well as to begin to recover lost revenue, hospitals need to go beyond offering the same virtual health convenience as their competitors Livango and Teladoc should have been a shot across the bow for every health system in 2020. Moreover, hospitals need to become marketing organizations. Like any for-profit brand, hospitals need to devote significant resources to building loyalty but have traditionally eschewed many of the cutting-edge marketing techniques used in other industries. Engagement and personalization at every step of the patient journey will be core to those efforts.

Marc Probst, former Intermountain Health System CIO, Advisor for SR Health by Solutionreach

Healthcare will fix what its lacking mostcommunication.

Because every patient and their health is unique, when it comes to patient care, decisions need to be customized to their specific situation and environment, yet done in a timely fashion. In my two decades at one of the most innovative health systems in the U.S., communication, both across teams and with patients continuously has been less than optimal. I believe we will finally address both the interpersonal and interface communication issues that organizations have faced since the digitization of healthcare.

Rich Miller, Chief Strategy Officer, QGenda

2021 The year of reforming healthcare: Weve been looking at ways to ease healthcare burdens for patients for so long that we havent realized the onus weve put on providers in doing so. Adding to that burden, in 2020 we had to throw out all of our playbooks and become masters of being reactive. Now, its time to think through the lessons learned and think through how to be proactive. I believe provider-based data will allow us to reformulate our priorities and processes. By analyzing providers biggest pain points in real-time, we can evaporate the workflow and financial troubles that have been bothering organizations while also relieving providers of their biggest problems.

Robert Hanscom, JD, Vice President of Risk Management and Analytics at Coverys

Data Becomes the Fix, Not the Headache for Healthcare

The past 10 years have been challenging for an already overextended healthcare workforce. Rising litigation costs, higher severity claims, and more stringent reimbursement mandates put pressure on the bottom line. Continued crises in combination with less-than-optimal interoperability and design of health information systems, physician burnout, and loss of patient trust, have put front-line clinicians and staff under tremendous pressure.

Looking to the future, it is critical to engage beyond the day to day to rise above the persistent risks that challenge safe, high-quality care on the frontline. The good news is healthcare leaders can take advantage of tools that are available to generate, package, and learn from data and use them to motivate action.

Steve Betts, Chief of Operations and Products at Gray Matter Analytics

Analytics Divide Intensifies: Just like the digital divide is widening in society, the analytics divide will continue to intensify in healthcare. The role of data in healthcare has shifted rapidly, as the industry has wrestled with an unsustainable rate of increasing healthcare costs. The transition to value-based care means that it is now table stakes to effectively manage clinical quality measures, patient/member experience measures, provider performance measures, and much more. In 2021, as the volume of data increases and the intelligence of the models improves, the gap between the haves and have nots will significantly widen at an ever-increasing rate.

Substantial Investment in Predictive Solutions: The large health systems and payors will continue to invest tens of millions of dollars in 2021. This will go toward building predictive models to infuse intelligent next best actions into their workflows that will help them grow and manage the health of their patient/member populations more effectively than the small and mid-market players.

Jennifer Price, Executive Director of Data & Analytics at THREAD

The Rise of Home-based and Decentralized Clinical Trial Participation

In 2020, we saw a significant rise in home-based activities such as online shopping, virtual school classes and working from home. Out of necessity to continue important clinical research, home health services and decentralized technologies also moved into the home. In 2021, we expect to see this trend continue to accelerate, with participants receiving clinical trial treatments at home, home health care providers administering procedures and tests from the participants home, and telehealth virtual visits as a key approach for sites and participants to communicate. Hybrid decentralized studies that include a mix of on-site visits, home health appointments and telehealth virtual visits will become a standard option for a range of clinical trials across therapeutic areas. Technological advances and increased regulatory support will continue to enable the industry to move out of the clinic and into the home.

Doug Duskin, President of the Technology Division at Equality Health

Value-based care has been a watchword of the healthcare industry for many years now, but advancement into more sophisticated VBC models has been slower than anticipated. As we enter 2021, providers particularly those in fee-for-service models who have struggled financially due to COVID-19 and payers will accelerate this shift away from fee-for-service medicine and turn to technology that can facilitate and ease the transition to more risk-bearing contracts. Value-based care, which has proven to be a more stable and sustainable model throughout the pandemic, will seem much more appealing to providers that were once reluctant to enter into risk-bearing contracts. They will no longer be wondering if they should consider value-based contracting, but how best to engage.

Brian Robertson, CEO of VisiQuate

Continued digitization and integration of information assets: In 2021, this will lead to better performance outcomes and clearer, more measurable examples of return on data, analytics, and automation.

Digitizing healthcares complex clinical, financial, and operational information assets: I believe that providers who are further in the digital transformation journey will make better use of their interconnected assets, and put the healthcare consumer in the center of that highly integrated universe. Healthcare consumer data will be studied, better analyzed, and better predicted to drive improved performance outcomes that benefit the patient both clinically and financially.

Some providers will have leapfrog moments: These transformations will be so significant that consumers will easily recognize that they are receiving higher value. Lower acuity telemedicine and other virtual care settings are great examples that lead to improved patient engagement, experience and satisfaction. Device connectedness and IoT will continue to mature, and better enable chronic disease management, wellness, and other healthy lifestyle habits for consumers.

Kermit S. Randa, CEO of Syntellis Performance Solutions

Healthcare CEOs and CFOs will partner closely with their CIOs on data governance and data distribution planning. With the massive impact of COVID-19 still very much in play in 2021, healthcare executives will need to make frequent data-driven and often ad-hoc decisions from more enterprise data streams than ever before. Syntellis research shows that healthcare executives are already laser-focused on cost reduction and optimization, with decreased attention to capital planning and strategic growth. In 2021, there will be a strong trend in healthcare organizations toward new initiatives, including clinical and quality analytics, operational budgeting, and reporting and analysis for decision support.

Dr. Calum Yacoubian, Associate Director of Healthcare Product & Strategy at Linguamatics

As payers and providers look to recover from the damage done by the pandemic, the ability to deliver value from data assets they already own will be key. The pandemic has displayed the siloed nature of healthcare data, and the difficulty in extracting vital information, particularly from unstructured data, that exists. Therefore, technologies and solutions that can normalize these data to deliver deeper and faster insights will be key to driving economic recovery. Adopting technologies such as natural language processing (NLP) will not only offer better population health management, ensuring the patients most in need are identified and triaged but will open new avenues to advance innovations in treatments and improve operational efficiencies.

Prior to the pandemic, there was already an increasing level of focus on the use of real-world data (RWD) to advance the discovery and development of new therapies and understand the efficacy of existing therapies. The disruption caused by COVID-19 has sharpened the focus on RWD as pharma looks to mitigate the effect of the virus on conventional trial recruitment and data collection. One such example of this is the use of secondary data collection from providers to build real-world cohorts which can serve as external comparator arms.

This convergence on seeking value from existing RWD potentially affords healthcare providers a powerful opportunity to engage in more clinical research and accelerate the work to develop life-saving therapies. By mobilizing the vast amount of data, they will offer pharmaceutical companies a mechanism to positively address some of the disruption caused by COVID-19. This movement is one strategy that is key to driving provider recovery in 2021.

Rose Higgins, Chief Executive Officer of HealthMyne

Precision imaging analytics technology, called radiomics, will increasingly be adopted and incorporated into drug development strategies and clinical trials management. These AI-powered analytics will enable drug developers to gain deeper insights from medical images than previously capable, driving accelerated therapy development, greater personalization of treatment, and the discovery of new biomarkers that will enhance clinical decision-making and treatment.

Dharmesh Godha, President and CTO of Advaiya

Greater adoption and creative implementation of remote healthcare will be the biggest trend for the year 2021, along with the continuous adoption of cloud-enabled digital technologies for increased workloads. Remote healthcare is a very open field. The possibilities to innovate in this area are huge. This is the time where we can see the beginning of the convergence of personal health aware IoT devices (smartwatches/ temp sensors/ BP monitors/etc.) with the advanced capabilities of the healthcare technologies available with the monitoring and intervention capabilities for the providers.

Simon Wu, Investment Director, Cathay Innovation

Healthcare Data Proves its Weight in Gold in 2021

Real-world evidence or routinely stored data from hospitals and claims, being leveraged by healthcare providers and biopharma companies along with those that can improve access to data will grow exponentially in the coming year. There are many trying to build in-house, but similar to autonomous technology, there will be a separate set of companies emerge in 2021 to provide regulated infrastructure and have their AWS moment.

Kyle Raffaniello, CEO of Sapphire Digital

2021 is a clear year for healthcare price transparency

Over the past year, healthcare price transparency has been a key topic for the Trump administration in an effort to lower healthcare costs for Americans. In recent months, COVID-19 has made the topic more important to patients than ever before. Starting in January, we can expect the incoming Biden administration to not only support the existing federal transparency regulations but also continue to push for more transparency and innovation within Medicare. I anticipate that healthcare price transparency will continue its momentum in 2021 as one of two Price Transparency rules takes effect and the Biden administration supports this movement.

Dennis McLaughlin VP of Omni Operations + Product at ibi

Social Determinants of Health Goes Mainstream: Understanding more about the patient and their personal environment has a hot topic the past two years. Providers and payers ability to inject this knowledge and insight into the clinical process has been limited. 2021 is the year it gets real. Its not just about calling an uber anymore. The organizations that broadly factor SDOH into the servicing model especially with virtualized medicine expanding broadly will be able to more effectively reach vulnerable patients and maximize the effectiveness of care.

Joe Partlow, CTO at ReliaQuest

The biggest threat to personal privacy will be healthcare information: Researchers are rushing to pool resources and data sets to tackle the pandemic, but this new era of openness comes with concerns around privacy, ownership, and ethics. Now, you will be asked to share your medical status and contact information, not just with your doctors, but everywhere you go, from workplaces to gyms to restaurants. Your personal health information is being put in the hands of businesses that may not know how to safeguard it. In 2021, cybercriminals will capitalize on rapid U.S. telehealth adoption. Sharing this information will have major privacy implications that span beyond keeping medical data safe from cybercriminals to wider ethics issues and insurance implications.

Jimmy Nguyen, Founding President at Bitcoin Association

Blockchain solutions in the healthcare space will bring about massive improvements in two primary ways in 2021.

Firstly, blockchain applications will for the first time facilitate patients owning, managing, and even monetizing their personal health data. Todays healthcare information systems are incredibly fragmented, with patient data from different sources be they physicians, pharmacies, labs, or otherwise kept in different silos, eliminating the ability to generate a holistic view of patient information and restricting healthcare providers from producing the best health outcomes.

Healthcare organizations are growing increasingly aware of the ways in which blockchain technology can be used to eliminate data silos, enable real-time access to patient information, and return control to patients for the use of their personal data all in a highly-secure digital environment. 2021 will be the year that patient data goes blockchain.

Secondly, blockchain solutions can ensure more honesty and transparency in the development of pharmaceutical products. Clinical research data is often subject to questions of integrity or hygiene if data is not properly recorded, or worse, is deliberately fabricated. Blockchain technology enables easy, auditable tracking of datasets generated by clinical researchers, benefitting government agencies tasked with approving drugs while producing better health outcomes for healthcare providers and patients. In 2021, I expect to see a rise in the use and uptake of applications that use public blockchain systems to incentivize greater honesty in clinical research.

Alex Lazarow, Investment Director, Cathay Innovation

The Future of US Healthcare is Transparent, Fair, Open and Consumer-Driven

In the last year, the pandemic put a spotlight on the major gaps in healthcare in the US, highlighting a broken system that is one of the most expensive and least distributed in the world. While weve already seen many boutique healthcare companies emerge to address issues around personalization, quality and convenience, the next few years will be focused on giving the power back to consumers, specifically with the rise of insurtechs, in fixing the transparency, affordability, and incentive issues that have plagued the private-based US healthcare system until now.

Lisa Romano, RN, Chief Nursing Officer, CipherHealth

Hospitals will need to counter the staff wellness fallout

The pandemic has placed unthinkable stress on frontline healthcare workers. Since it began, theyve been working under conditions that are fundamentally more dangerous, with fewer resources, and in many cases under the heavy emotional burden of seeing several patients lose their battle with COVID-19. The fallout from that is already beginning doctors and nurses are leaving the profession, or getting sick, or battling mental health struggles. Nursing programs are struggling to fill classes. As a new wave of the pandemic rolls across the country, that fallout will only increase. If they havent already, hospitals in 2021 will place new premiums upon staff wellness and staff health, tapping into the same type of outreach and purposeful rounding solutions they use to round on patients.

Kris Fitzgerald, CTO,NTT DATA Services

Quality metrics for health plans like data that measures performance was turned on its head in 2020 due to delayed procedures. In the coming year, we will see a lot of plans interpret these delayed procedures flexibly so they honor their plans without impacting providers. However, for so long, the payers use of data and the providers use of data has been disconnected. Moving forward the need for providers to have a more specific understanding of what drives the value and if the cost is reasonable for care from the payer perspective is paramount. Data will ensure that this collaboration will be enhanced and the concept of bundle payments and aligning incentives will be improved. As the data captured becomes even richer, it will help people plan and manage their care better. The addition of artificial intelligence (AI) to this data will also play a huge role in both dialog and negotiation when it comes to cost structure. This movement will lead to a spike in value-based care adoption

RELATED: M&A: Ro Acquires On-Demand, In-Home Platform Workpath

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Here is the original post:
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 - - HIT Consultant

Read the Rest...

6 Health Benefits of Drinking Pickle Juice – Health Essentials from Cleveland Clinic

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on 6 Health Benefits of Drinking Pickle Juice – Health Essentials from Cleveland Clinic

Next time you open a jar of crunchy pickles, save the juice! Maybe youve always loved that mouth-watering pucker. Or, maybe the thought of drinking straight pickle juice sounds unappetizing. Whether you love it or hate it, pickle juice may be good for your health.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pickle juice does have some benefits, but it really depends. The type of pickle juice matters. So does the health benefit youre looking to gain, says functional medicine dietitian Camille Skoda, RDN, LD, IFNCP. A jar thats full of dyes and preservatives wont give you those benefits.

Skoda gives six ways pickle juice is good for you and how to reap the benefits.

Naturally fermented pickles and their juice contain helpful microorganisms called probiotics. Probiotics are live, microscopic bacteria and yeasts that you can also find in:

Your gut contains many bacteria species that are beneficial for metabolism, overall health, digestion and fighting sicknesses. Theyre also linked to less anxiety, depression and better mood, explains Skoda.

Probiotics can help keep your good gut bacteria in balance. People eat probiotics for these benefits, especially to aid digestion.

Skoda says you can find probiotics in refrigerated pickles that are not vinegar-based. They should be fermented naturally in water using salt and spices.

To get these benefits, try eating a pickle a day. But keep in mind that everybody tolerates probiotics differently. So if youre drinking pickle juice for the probiotics, start with a small amount, Skoda recommends. And dont drink so much that you overdo it on the sodium.

Electrolytes help maintain the fluid balance in your body and keep all systems firing. But when you sweat, you risk losing too many. The antidote?

Pickle juice contains electrolytes in the form of a lot of sodium and some potassium and magnesium. Thats why you can use it as a natural electrolyte, says Skoda. It can help to rehydrate after exercise.

To get the most benefit, Skoda says to choose a vinegar-based pickle without yellow dye and preservatives. Using pickle juice as an electrolyte may work well for people who:

But using pickle juice as your go-to recovery drink isnt for everyone. The recommendation is to have no more than 2,300 milligrams of sodium each day. And 3 ounces of pickle juice gives you 900 mg right there, depending on the brand, she says. You can find electrolyte supplements that only have 150 mg of sodium and more potassium and magnesium instead.

Studies show that vinegar can help prevent spikes and dips in blood sugar. Thats a check in the win column for vinegar-based pickle juices. You would also see the same benefits from vinegar-based salad dressings and apple cider vinegar, adds Skoda.

The research gets a little murkier when it comes to pickle juices effects on weight loss. But its also less about the pickles and more about vinegar.

Pickle juice could help curb your appetite by stabilizing blood sugar. Its easier to lose weight and control appetite when your blood sugars stable, says Skoda. And if youre drinking pickle juice for the probiotic benefit, improving digestion and metabolism could definitely help you lose weight.

Drinking too much alcohol can dehydrate you. Electrolytes can help reduce some of those effects, says Skoda. Drinking pickle juice as a hangover cure can help if its the electrolyte you choose.

Score one for the cucumbers! Since pickles are fermented cukes, you get to count some of that veggie goodness, including vitamins, minerals and antioxidants.

Antioxidants may protect your cells from damage caused by free radicals. Free radicals are molecules inside the body that are linked to cancer, heart disease and more. You can get some antioxidants from pickle juice, but eating the pickle is more beneficial.

Skodas bottom line: If you like the briny goodness of pickles or pickle juice, bon appetit! While pickle juice is not a cure-all, it can definitely be part of a healthy eating plan.

Visit link:
6 Health Benefits of Drinking Pickle Juice - Health Essentials from Cleveland Clinic

Read the Rest...

‘Early Diagnosis and Treatment Pivotal to Keep IBD at Bay’ – eHealth Magazine – Elets

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on ‘Early Diagnosis and Treatment Pivotal to Keep IBD at Bay’ – eHealth Magazine – Elets





Listen to this Article

Inflammatory Bowel Disease, an autoimmune disease mainly affect intestine. It needs early attention to not let it becomes fatal. Dr Piyush Ranjan, Senior Consultant, Institute of Liver Gastroenterology & Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, Delhi, explains various aspects of the disease, symptoms, precautions, and treatment measures, in an exclusive interview with Harshal Desai of Elets News Network (ENN).

Q You have years of experience tackling IBD patients at topmost hospitals. Tell us what exactly is IBD and how is it affecting Indians.

IBD basically stands for Inflammatory Bowel Disease. It comprises malfunction in the digestive system involving intestine. There are the two major types-the most common being, Ulcerative Colitis and Crohns disease. Ulcerative colitis involves the large intestine while Crohns disease occurs in bothlarge and small intestine. Then there are indeterminate colitis and microscopic colitis- these are the sub type of IBD.

Q Hows this trend different from the other trend we have in India. How is this different from the growing global trend?

Yes, the global trend is the same. Initially people used to believe that Crohns disease does not exist in India or it has low prevalence in India. Moreover, due to different presentations, it was confused with Intestinal Tuberculosis. Now with better diagnostic test, we are finding that Crohns is being diagnosed more and more. In addition, people who were previously treated for Intestinal Tuberculosis later turned out to be Crohns Disease. Crohns disease relevance has been increasing in India mainly because of better diagnostic tests and better awareness among the doctors.

Q Brief us about the reasons why it happens? Does our routine life like working under stress, long office hours are some of the reasons for IDP?

There are many, but the exact reason of this disease is not known. Mainly these diseases are autoimmune in nature. Autoimmune disease means those diseases which occur because of the damage in the body by its own immune system. In this case, own immune system recognize a particular organ as foreign origin. Because this is it matter of speculation. Some genetic disposition has been found but one to one correlation has not been seen yet. It oscillates about the triggering event. An industrial bacterium is one of the postulates. But in a sense, it is because of the damage of intestine by a persons own immune system.

Also read: Technology enables better outcome on diagnosis, treatment

Q Does it mean that you need to have a strong immune system to fight of this disease?

No, actually a strong immune system damages you; so it is a misbalance. It is a failed recognition of the self-tissue. Its not like these people are not susceptible to other infection. Its just that there immune cells start damaging any tissueit may be liver or in case of ulcerative disease it is intestine.

Q What is the diagnosis process and what are the possible treatments in the country right now?

Diagnostic process starts from the symptoms. Whenever someone has blood mixed diarrhea, it is most likely that person is suffering from ulcerative colitis. The diagnosis test for this type of diseases is the colonoscopy. Endoscopy is done from the oral route; colonoscopy is done from the rectal route. Endoscope is passed through the rectum and large intestine is examined directly. The appearance of ulcerative colitis is very characteristic but still to confirm it a biopsy is taken though this is nothing to do with malignancy. People get scared too much when they are told about that biopsy has been undertaken. Ulcerative colitis diagnosis process involves colonoscopy and taking the intestinal biopsy. This is very simple for ulcerative colitis. For Crohns disease, we may examine small intestine with the help of a Capsule Endoscopy. There are other ancillary tests but they are not as credible as this to establish the diagnosis

This disease requires life-long treatment, the most important thing which has to be understood. There are many drugs available. The choice of drugs depends upon the location where the disease is in the intestine exactly. Then the severity of disease is another factor. According to the severity of the disease, various drugs are prescribedlike the oldest drugs which are five amino salicylate. Then there are oral steroids, other immune suppressive drugs like azathioprine methotrexate and newer drugs which are known as biological drugs- -anti TNF Alpha drugs,

So, which drug one would choose depends on the severity of the disease. For active disease, stronger medicine is required to first bring disease into control and once the disease has been brought under control then a different group of drug is required to maintain that statethat is ignored remission.

The most common cause of a person having uncontrolled disease recurrent is over compliance to the treatment. People often stop their treatment and start taking alternative options which leads to loss of control of disease.

Q What are the challenges you face while diagnosing IBD diseases?

One of the most common challenges is when a person is having bleeding. Doctor very often misdiagnosed as having hemorrhoidthat is piles. They undergo surgery because they do not undergo a colonoscopy, so any person having bleeding, sigmoidoscopy or colonoscopy at the onset is the bare minimum which is required.

So one needs to understand that this is a possibility and unless and until a test is done it will not be possible to diagnose this. Patients have to be counseled for depression that is a major challenge. These drugs have some side effects too, so monitoring is very necessary.

In this COVID time, people have stopped coming for checkups. This may lead to relapse that the disease coming back more strongly. One particular problem in our country is proclivity for alternative medicines like Ayurvedic and Homeopathic. People fall in that trap often. When they are promised that theyll be given some medicines which will not have any side effects, they go for it. These are some of the challenges.

Q Do we have cure in Ayurveda and Homeopathy for this disease?

They claim but you must have read that patanjali has found the cure for coronavirus but anything that is claimed has to be proved by a scientific mean. As a scientist you cannot say no to anything. They may have a cure but you need scientific proof which they dont have.

Q Due to lockdown, IBD may have taken toll on lots of IBD patients. What is your take?

A: Absolutely any person with long standing chronic disease need to visit doctor on regular interval but due to lockdown they are averse to visit doctors. They are scared to come to the hospital due to fear of catching infection. So not only Ulcerative, people with many different diseases, non COVID diseases are facing a lot of problem because of their reluctance to come to the hospital to seek help.

Q Recently I read a report that people with inflammatory bowel disease are at the high risk of dementia, do you think so?

As I told you these medicines decrease the immunity level. So there are groups of medicines among medicines which are being used for treatment of IBD which might put a person to higher risk for developing COVID. But the fact is again continuation or discontinuation. There are very clear cut guidelines for that and you actually need to take guidance of a Gastroenterologist to decidedepending on the activity of the disease, the past behavior of the disease, and the current needle that is their control.

Q What message would you like to give to people who are suffering from IBD?

Get yourself diagnosed early if youre having such symptoms. Discuss with the doctor. Accept that you are having a problem and accept the fact is this disease requires a life-long treatment, this is the most important thing. You need regular follow up to look at the activity of disease and monitor the side effects of the drugs. If you do this, nearly 90% people will have a very good course. 80 to 90% will have a very good and smooth coursethere will be intermittent some bumps on the way but most of the people can have the normal productive active life.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Read more from the original source:
'Early Diagnosis and Treatment Pivotal to Keep IBD at Bay' - eHealth Magazine - Elets

Read the Rest...

Optimism may be irrational, but it’s helping me get through this pandemic – The Guardian

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on Optimism may be irrational, but it’s helping me get through this pandemic – The Guardian

Looking back on when my mum died several years ago, it would be easy for me to count every time I thought she might live as a moment of stupidity.

She had stage four lung cancer. Even with the best treatment in the world, her chances of getting through it were minuscule. But that didnt stop me from crying tears of joy when, a few weeks after she started immunotherapy, I saw a scan showing that the tumour had shrunk. I tried to stop myself, but images of her strong, and loud, and cackling her head off again flooded my mind. Anxious people know what it is to be a slave to the eternal what if?, but what if the what if is about everything going right?

Even as I held her limp hand in the ambulance to the hospice, a microscopic but irrepressible part of me thought a 180-degree turn was possible. She was still my mum; she still said fuck a lot, and loved us aggressively, and had red hair, even though the grey roots were slowly taking over. But yes, it was deranged at this point for me to hope for anything other than an end to my mums pain. But sometimes deranged is exactly what you need.

Optimism gets a bad rap. Sometimes rightly so. This year, obviously, optimism has been partially responsible for a lot of idiocy. Its just flu, said the optimists, as they continued to lick handrails well into April. And of course, theres been a lot of dangerously optimistic rhetoric (sincere or otherwise) from Boris let the plebs die of Christmas Johnson. Optimism can be a gateway drug to either recklessness or passivity. But the year my mum died and once again this year I couldnt have survived without it.

In the last month of the cursed year that is 2020, the urge to tell myself that everything is basically going to be OK has become a need. Unfortunately, this does mean (internally at least) screaming SHUT UP at every well-meaning, scientifically minded person who brings up potential difficulties in the post-vaccine Covid world. But it also means being able to get through days, and even weeks, with the minimum number of depressive breakdowns.

I have a good feeling about next year, I heard myself say to the dejected looking barista at a local cafe. As much as hearing those words come out of my mouth was like an out-of-body experience (and as much as I immediately regretted it as thoughts of the virus developing the ability to shoot guns seeped in) I clearly needed to get my optimism off my chest. Even if the barista didnt seem convinced, and I had to panic about having come across like someone who had recently joined a cult.

After all, Boris Johnson did kick off this hell year with that This is going to be a fantastic year for Britain tweet. Which quickly became a meme about how precisely un-great a year this has been for Britain (or the rest of the world). His double thumbs up in the accompanying picture crystallising the irony into something truly grotesque.

But if optimism is a drug, then using it sensibly is really all about the dosage. Like my antidepressants, optimism should be taken daily, in the correct amount. Too much could kill me, and too little would send me into a ditch of withdrawal. Optimism needs to be balanced out with reverence for bad news, but it also needs to be enjoyed for what it is. Thoughts of hugging my friends, or masklessly huffing the smell of baked goods in Sainsburys, are medicinal. I also appreciate that actual medicine is medicinal, and if those making it are telling us to manage our expectations, we should probably listen to them.

Is it true optimism, though, if you know youre deluded? Well, no one would buy lottery tickets if there wasnt a teeny bit of them that thought they might win. Optimism, I find, is often about the fantasy of things going right. When I buy a lottery ticket, I essentially pay 2 to spend a few days living in my head the life of someone who just won tens of millions of pounds. I buy a house and some incredibly expensive kitchen knives. I eventually have an existential crisis about having been allocated a vast sum of money at random (optimism is fairly new to me, and Im not always good at it).

When my mum was very ill, my thoughts would often take me to the darkest places imaginable. It was only fair then that sometimes I also allowed them to take me to a deranged fantasy land, where my mum had colour in her cheeks, and cancers shrivelled like old grapes. When everything goes to shit, thinking we can smell roses doesnt make us stupid, it makes us human.

Visit link:
Optimism may be irrational, but it's helping me get through this pandemic - The Guardian

Read the Rest...

Dharma And Diaspora: Pankaj Jain’s Book Sheds Light On Impact Of Indic Communities In USA, And The Possible Dangers That Await Them – Swarajya

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on Dharma And Diaspora: Pankaj Jain’s Book Sheds Light On Impact Of Indic Communities In USA, And The Possible Dangers That Await Them – Swarajya

The book also brings out interesting political developments as the colonised people started asserting their rights.

Here is a very interesting fact from the book.

In 1906, there was a Pan-Aryan Association in the United States.

No, it was not a white supremacist organisation. Actually, it was co-founded by Mohammed Barkatullah (president) and Samuel Louis Joshi, and their inspiration was Shyamji Krishna Varma.

The movement was for the cause of Irish revolutionaries (p.19).

So, even in the early 20th century, Indians have been using the term Aryan in their own traditional, non-racial way, to fight for human rights, transcending racial and religious barriers.

The book highlights, in the chapter on the freedom movement, the Hindu German Conspiracy and the Ghadar movement, among others.

The Hindu German Conspiracy trial held in San Francisco between November 1917 and April 1918 was a blow to US-based activities of Indian revolutionaries.

Yet, it helped sensitise American public opinion and to an extent, move it in favour of Indian Independence.

The New York Times, now a promoter of stereotypes of cultural racism against India, then even published an article by Lala Lajpat Rai, which argued the case of Indian freedom based on the values of liberty and democracy (p.22).

As said earlier, the book specifically deals with three important aspects usually not discussed in other books on the same subject the way Ayurveda has entered mainstream American culture, the influence of Indian music and the Jains in the US.

Read the rest here:
Dharma And Diaspora: Pankaj Jain's Book Sheds Light On Impact Of Indic Communities In USA, And The Possible Dangers That Await Them - Swarajya

Read the Rest...

Covid-19 one year on: Dark clouds and silver linings for Singapore amid pandemic – The Straits Times

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on Covid-19 one year on: Dark clouds and silver linings for Singapore amid pandemic – The Straits Times

Many Singaporeans step up to give their time, money to the needy

The coronavirus and efforts to stem its spread took a massive toll on the economy this year, with a sharp rise in workers losing their jobs or taking a steep pay cut.

But the darkest of times also brought out the best in Singaporeans, many of whom stepped forward, to give money or their time to help.


As the threat of contracting the coronavirus on public transport and in densely packed office spaces loomed, employees from all over the globe bade their workplaces goodbye and hunkered down at home to work.

Lights in office towers went out, and business districts fell silent. Office desks were swopped for makeshift studies at home, and meetings replaced by teleconferencing calls.


The Covid-19 pandemic threw a wicked curveball at the tourism industry this year when countries closed their borders to keep out the virus.

As air travel dwindled to nearly nothing, national carrier Singapore Airlines recorded itsfirst annual net loss in its 48-year history.


To escape the scourge of a contagious, microscopic foe, various nations went into lockdown earlier this year.

As people were confined to their homes, cars stowed away and industrial activities slowed, it was as though an invisible broom had swept away the pall of smog, soot and harmful pollutants, to reveal clear skies.


In times of crisis, vulnerabilities become especially apparent.

For Singapore,the empty supermarket shelves during the early days of the Covid-19 pandemicwere but a symptom of a larger worry for a nation that imports most of its food: food security.


In April, when Covid-19 infections showed no signs of abatingand the evidence was growing in favour of wearing face masks to prevent transmissions,it became compulsory for everyoneto don one that covered their mouths and noses as long as they were not at home.

People soon learnt that the authorities meant business when those who for whatever reason did not have a mask onfaced fines.


A once-in-a-century global pandemic has disrupted lives, killed people, upended commerce, shuttered businesses, destroyed jobs and simply caused untold chaos to the order in our lives.

One of the darkest shadows it cast was the way it reinforced inequities.


Covid-19will not be the world's last pandemic.Many of us may even live to see the next one, but we are unlikely to be any more prepared for it than we were for this one.

That is the bleak opinion of Dr Kenneth Iserson, professor emeritus of emergency medicine at the University of Arizona in the United States, who specialises in global and disaster medicine.


Singapore, this chart will show you why your personal sacrifices - no travel, stay-at-home, circuit breaker - have made all the difference this past year.


Continued here:
Covid-19 one year on: Dark clouds and silver linings for Singapore amid pandemic - The Straits Times

Read the Rest...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – LionLowdown

§ January 5th, 2021 § Filed under Nano Medicine Comments Off on Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – LionLowdown

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

Nanomedicine Market Drivers and Restrains: Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.


The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis: Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis: Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscape Major Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.


Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics Treatments Nanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological Diseases Nanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives Oncology Nanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East Africa Nanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.


Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at:

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage


Email: [emailprotected]

Contact: +919607065656/ +919607195908

Follow this link:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - LionLowdown

Read the Rest...

Nanotechnology and Nanomaterials Market (Covid-19 Analysis) SWOT Analysis, Key Indicators, Forecast 2028 | BASF SE, Minerals Technologies Inc,…

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on Nanotechnology and Nanomaterials Market (Covid-19 Analysis) SWOT Analysis, Key Indicators, Forecast 2028 | BASF SE, Minerals Technologies Inc,…

Company Profile

The global Nanotechnology and Nanomaterials market research report covers market attractiveness analysis, where each segment of the market is benchmarked based on its market size, growth rate and general appeal. The global Nanotechnology and Nanomaterials marketis expected to achieve market growth as well as upcoming market opportunities or challenges in the forecast period of 2020 to 2027. The company researcher analyses the market is mounting at a vigorous CAGR in the forecast period.

Moreover, the global Nanotechnology and Nanomaterials market research analysis report also provides the complete details on the major elements of the market like mergers and acquisition of the major key players, research and development activities, new product launches, product pricing and Covid-19 impact on the major players of the market. The global Nanotechnology and Nanomaterials market research report covers estimation of the market from 2020-2027 and historical information from 2015-2019.

Global Nanotechnology and Nanomaterials Market by Types:

Global Nanotechnology and Nanomaterials Market by Applications:

Global Nanotechnology and Nanomaterials Market by Geographical Region:

Enquire Here for, Report Enquire, Discount and Customization:

The Market Coverage chapter in the market research report provides an important assessment of market segments like market types, application and region, also provides application view, significant makers, product offerings and measure period.

The Outline chapter in the market research report emphases on all the key market drivers, restrains and market limitations, which helps the growth of the global Nanotechnology and Nanomaterials market in the current and forecast period. Along with this, this chapter also provides market development rate, drive market patterns and major market viewpoints.

The Regional Analysis chapter in the market research report focuses on all the division and sub-division across the globe. In this chapter, the marketers analyze and evaluate the most recent market import and fare patterns, along with this, the report also provides information on the production and utilization quantities of the Nanotechnology and Nanomaterials products. The market major parts in every area and income period details are also covered in the global Nanotechnology and Nanomaterials market research report.

Choose Require Company Profile Data from list:

Takeaway points from this report:

Buy single user with discounted price now:

About Us:

We at Zeal Insider aim to be global leaders in qualitative and predictive analysis as we put ourselves in the front seat for identifying worldwide industrial trends and opportunities and mapping them out for you on a silver platter. We specialize in identifying the calibers of the markets robust activities and constantly pushing out the areas which allow our clientele base in making the most innovative, optimized, integrated and strategic business decisions in order to put them ahead of their competition by leaps and bounds. Our researchers achieve this mammoth of a task by conducting sound research through many data points scattered through carefully placed equatorial regions.

Contact Us:

Zeal Insider 1st Floor, Harikrishna Building, Samarth Nagar, New Sanghvi, Pune- 411027 India tel: +91-8149441100 (GMT Office Hours) tel: +17738002974

See the original post here:

Nanotechnology and Nanomaterials Market (Covid-19 Analysis) SWOT Analysis, Key Indicators, Forecast 2028 | BASF SE, Minerals Technologies Inc,...

Read the Rest...

New Nanotechnology-Based Diagnostic System Detects COVID-19 Within 10 Seconds – HospiMedica

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on New Nanotechnology-Based Diagnostic System Detects COVID-19 Within 10 Seconds – HospiMedica

Image: Diagnovir (Photo courtesy of Bilkent University)

A team of researchers from the Bilkent University (Ankara, Turkey) has developed an in vitro virus diagnosis system that can be used to detect the SARS-CoV-2 virus. The new nanotechnology-based diagnostic system, called Diagnovir, can detect the COVID-19 virus within 10 seconds with a swab taken from the mouth. It is an optically based diagnostic and identification system that changes the color of the glow in the presence of the virus, thus detecting viruses with high selectivity.

In this system, pathogens are detected within 10 seconds by dynamically receiving a fluorescent signal via a pathogen detection chip developed specifically for a biosensor device. After the sample is taken from the patient, it is mixed with a special solution, dropped on the pathogen detection chip, and if there is a pathogen in the environment by the biosensor device, the presence of pathogens with high accuracy is detected by taking the fluorescent signal.

Unlike the commonly used PCR tests, the system is not based on sample replication, but on detecting the presence or absence of the virus with advanced optical methods. In the system, optical and electronic modules that provide both precise virus detection and high selectivity in detection, as well as high-level biotechnology and material science knowledge are used. The system has shown 99% success in virus detection in pre-clinical studies conducted so far.

Related Links:Bilkent University

Read more here:

New Nanotechnology-Based Diagnostic System Detects COVID-19 Within 10 Seconds - HospiMedica

Read the Rest...

NS Nanotech Teams Up with Kryptolights to Offer Far-UVC Sterilization for a Host of Consumer and Commercial Applications – PR Web

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on NS Nanotech Teams Up with Kryptolights to Offer Far-UVC Sterilization for a Host of Consumer and Commercial Applications – PR Web

NS Nanotech will highlight its ShortWaveLight Emitter technology at the virtual CES consumer electronics exhibition next week.

ANN ARBOR, Mich. (PRWEB) January 05, 2021

Kryptolights is utilizing revolutionary technology in a new suite of commercial and residential products poised to redefine the way we cleanse pathogens from the environment and interact with the world around us. Known as ShortWaveLight Emitters, NS Nanotechs groundbreaking nanotechnology neutralizes coronavirus and other pathogens with far-UVC disinfecting light.

At the virtual CES consumer electronics exhibition next week, NS Nanotech will highlight its ShortWaveLight Emitter technology, including applications that Kryptolights has under development to clean air and surfaces. Registered attendees will be able to visit the NS Nanotech virtual CES booth to learn more (search NS Nanotech in the CES exhibitor directory).

This essential technology is vital to curbing the current pandemic and in preventing one in the future. Many industries could utilize our products to regain peoples trust by offering customers a clean environment to conduct business, explains Kryptolights Co-Founder Shey Godoy. We know this tech will be a big part of the future. This spectrum of light offers normalcy, as it can seamlessly integrate into peoples businesses and lives.

Far UVC: A New Kind of UV Disinfection

The market for disinfection solutions utilizing ultraviolet light is 100 years old. But the COVID-19 pandemic set suppliers in the UV market on fire in 2020 to address the unprecedented disruption to the global economy and daily life for communities worldwide. The range of UV light known as far-UVC can inactivate pathogens, including coronaviruses, by attacking their RNA and making it impossible for them to reproduce. And recent scientific studies have found that with its short wavelength of 230 nanometers or less, far-UVC light does not penetrate living cells on the surfaces of skin and eyes.

Revolutionary solid-state nanotechnologies from NS Nanotech are making it practical to deploy shortwave far-UVC light in many settings, says Godoy. Unlike standard UV bulbs, which operate at high temperatures and require the use of caustic gases, the solid-state ShortWaveLight Emitters run cool, are smaller, and do not use dangerous materials. Whereas previous UV emitters were difficult to operate, now we can bring Kryptolights UltraClean solutions to the market and make a difference in everyones lives.

We are delighted to announce our partnership with Kryptolights on the eve of CES, where we can showcase the revolutionary properties and potential of far-UVC disinfecting light, says NS Nanotech CEO and Co-Founder Seth Coe-Sullivan. We designed our new solid-state far-UVC ShortWaveLight Emitters to be useful for thousands of applications that will protect consumers and businesses from coronavirus and future pathogens. Kryptolights is an early adopter already developing innovative far-UVC disinfection solutions that we expect will have a big impact in the near future and in coming years.

About NS Nanotech

NS Nanotechs patented technologies, drawing on a decade of work on nitride semiconductors by researchers at McGill University and the University of Michigan, dramatically improve the fabrication process and resulting efficiency of nano-scale light-emitting materials. NS Nanotech ShortWaveLight Emitters are the first devices that utilize solid-state semiconductors to generate far-UVC light.

About Kryptolights

Kryptolights is spearheading the advance of Far UVC technology into daily life. Utilizing expertise in spectrum-specific lighting and product brand UltraClean UV, germicidal lighting is coming to the residential and commercial marketplaces through products such as HomeSafe, Cleanse Light, and the Kryptolight Saber.

Share article on social media or email:

The rest is here:

NS Nanotech Teams Up with Kryptolights to Offer Far-UVC Sterilization for a Host of Consumer and Commercial Applications - PR Web

Read the Rest...

Nanotechnology in Medical Devices Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 – NeighborWebSJ

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on Nanotechnology in Medical Devices Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 – NeighborWebSJ

Data Bridge Market Research has recently added a concise research on the Nanotechnology in Medical Devices Market to depict valuable insights related to significant market trends driving the industry. The Nanotechnology in Medical Devices Market report is a window to the industry which talks about what market definition, classifications, applications, engagements and market trends are. This report analyzes the status and future forecast involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast in the major regions of the world. While formulating this market report, client business competence is understood adeptly to identify tangible growth opportunities. It provides the key manufacturers, presenting the sales, revenue, market share, and recent development for key players. The report makes some important proposals for a new project of industry before evaluating its feasibility.

This Nanotechnology in Medical Devices Market research report has been generated by considering a range of objectives of market research that are vital for the success of industry. This report showcases an idea about consumers demands, preferences, and their altering likings about particular product. A data triangulation method is applied for this purpose which entails data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. It estimates CAGR values in percentages which designate the rise or fall occurring in the market for particular product for the definite forecast period.

Nanotechnology in medical devices market is expected to reach a market value of USD 20.52 billion by 2027 growing with the CAGR of 11.9% in the forecast period of 2020-2027. The increasing support of the government in the provision on advanced technology has been directly impacting the growth of nanotechnology in medical devices market.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @

Increasing geriatric population along with rising occurrences of diseases across the globe and growing adoption and need of high and advanced technology for the treatment of chronic diseases will accelerate the growth of the nanotechnology in medical devices market in the forecast period of 20202-2027. Rising number of applications from the emerging countries and advancement to technology for rich mid to late stage product pipeline will further create new opportunities for the growth of the market in the above mentioned forecast period.

Strict rules and regulations that will consume time in product approval and increasing process of nanotechnology based medical devices will hamper the growth of the market in the forecast period of 2020-2027.

Competitive Landscape and Nanotechnology in Medical Devices Market Share Analysis

Nanotechnology in medical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanotechnology in medical devices market.

The major players covered in the nanotechnology in medical devices market report are 3M, Dentsply Sirona., Thermo Fisher Scientific Inc., PerkinElmer Inc, GENERAL ELECTRIC, Ferro Corporation, Eppendorf AG, Greiner Bio One International GmbH, ZELLMECHANIK DRESDEN, TV Rheinland, Medtronic, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Demant A/S, Cochlear Ltd., Sonova, MED-EL, DEKRA, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Nanotechnology in Medical Devices Market Scope and Market Size

Nanotechnology in medical devices market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Nanotechnology in Medical Devices Market Country Level Analysis

Nanotechnology in medical devices market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the nanotechnology in medical devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanotechnology in medical devices market because of prevalence of majority of nanotechnology based medical devices players and increasing government initiatives, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 because of increasing geriatric population, international research collaboration and increasing investment in research and development of nanotechnology.

The country section of the nanotechnology in medical devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

For More Insights Get FREE Detailed TOC @

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Nanotechnology in medical devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanotechnology in medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanotechnology in medical devices market. The data is available for historic period 2010 to 2018.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ [emailprotected]

More here:

Nanotechnology in Medical Devices Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 - NeighborWebSJ

Read the Rest...

Plus Therapeutics to Participate in Upcoming January Conferences – GlobeNewswire

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on Plus Therapeutics to Participate in Upcoming January Conferences – GlobeNewswire

January 05, 2021 16:15 ET | Source: Plus Therapeutics Inc.

AUSTIN, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:PSTV) (the Company), a clinical-stage company focused on making a positive impact on patients lives, today announced that Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics, will present at three upcoming virtual conferences.

Investors interested in arranging a meeting with the Companys management during the ICR Conference 2021 should contact the conference coordinator or Webcasts of the H.C. Wainwright and ICR conferences presentations will be available under the Events tab of the Investor Relations section of the Plus Therapeutics website at

About Plus Therapeutics, Inc.

Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Companys drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers. More information may be

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain statements that may be deemed forward-looking statements within the meaning of U.S. securities laws. All statements, other than statements of historical fact, that address activities, events or developments that we intend, expect, project, believe or anticipate and similar expressions or future conditional verbs such as will, should, would, could or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These statements include, without limitation, statements about: the Companys potential to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers; the Companys potential to develop drug candidates currently in its product pipeline; and the Companys potential to develop additional drugs outside of its current pipeline. The forward-looking statements included in this press release are subject to a number of additional material risks and uncertainties, including but not limited to: the risk that the Company is not able to successfully develop product candidates that can leverage the U.S. FDAs accelerated regulatory pathways; and the risks described under the heading Risk Factors in the Companys Securities and Exchange Commission filings, including in the Companys annual and quarterly reports. There may be events in the future that the Company is unable to predict, or over which it has no control, and its business, financial condition, results of operations and prospects may change in the future. The Company assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made unless the Company has an obligation under U.S. federal securities laws to do so.

Investor Contact Peter Vozzo Westwicke/ICR (443) 377-4767

Media Contact Terri Clevenger Westwicke/ICR (203) 856-4326

San Antonio, Texas, UNITED STATES


Formats available:

The rest is here:

Plus Therapeutics to Participate in Upcoming January Conferences - GlobeNewswire

Read the Rest...

Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines…

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines…

December 30, 2020 09:00 ET | Source: Avalon GloboCare Corp.

FREEHOLD, N.J., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced an update on its partnership with the Institute for Synthetic Bioarchitectures at the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria. The collaboration brings together BOKUs S-layer nanotechnology with Avalons expertise in biomanufacturing, cell therapy engineering, and clinical development.

Avalon plans to leverage the pioneering work of Professor Uwe B. Sleytr, a world-renowned scientist and pioneer in nanobiotechnology, who is among the foremost experts on basic and applied surface layer (S-layer) technology, and Professor Emeritus in the Department of Nanobiotechnology at BOKU. Professor Sleytr is also a member of Avalons Scientific and Clinical Advisory Board.

Applied S-layer nanotechnology enables the creation of uniform matrices of certain proteins or molecules and is based on the repetitive protein structures that make up the outer surface of microbial cells. Adding a coat of an S-layer onto solid surfaces can greatly improve the function of a therapeutic, vaccine, or device. The S-layer allows enhanced efficiency and interaction of targeted proteins and molecules for better function.

Avalon is currently utilizing S-layer technology to develop an intranasal, spray vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, and also for the development of additional vaccines, targeted drug delivery, diagnostic devices and other therapeutic applications.

Avalon and BOKU are establishing a state-of-the-art research facility, the Christian Doppler Laboratory, located on the BOKU campus in Vienna, Austria, under the scientific leadership of Professor Eva-Kathrin Ehmoser, the Head of BOKUs Institute for Synthetic Bioarchitectures and Professor Uwe Sleytr, a member of the Austrian Academy of Sciences. In connection with the new facility, Avalon and BOKU have signed a Memorandum of Understanding (MOU) to jointly apply for a matching research grant from the prestigious Christian Doppler Laboratory Foundation.

In the December 2020 issue of Natures Biopharma Dealmakers, Avalons President and CEO, David Jin, M.D., Ph.D., highlighted Avalons ongoing scientific and clinical developments including a first-in-human trial of a mucosal, intranasal vaccine against SARS-CoV-2 that is planned for early 2021. Dr. Jin also described the companys innovative, allogeneic mesenchymal stromal cell (MSC) therapy candidate, CB-MSC-1, which possess unique anti-inflammatory and immunomodulatory activities, as well as AVA-001, Avalons third-generation CAR T cell therapy that has shown robust activity in patients with relapsed, refractory B cell acute lymphoblastic leukemia in a Phase 1 trial (Avalon feature in Biopharma Dealmakers).

We are thrilled to fast-track our scientific and clinical research together with Avalon, as well as leverage Avalons clinical expertise and networks to translate these advancements into clinical programs, said Professor Ehmoser. We look forward to continuing this fruitful partnership.

We are excited and motivated to join forces with the researchers at BOKU to drive innovation. We have already begun a collaboration on the mucosal SARS-CoV-2 vaccine and are moving quickly to establish additional joint research endeavors to bring about innovative technologies and new medicines to patients, said Dr. Jin.

About Avalon GloboCare Corp.

Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX), and regenerative therapeutics. For more information about Avalon GloboCare, please visit

For the latest updates on Avalon GloboCare's developments, please follow our twitter at @avalongc_avco

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact Information: Avalon GloboCare Corp. 4400 Route 9, Suite 3100 Freehold, NJ 07728

Investor Relations: Crescendo Communications, LLC Tel: (212) 671-1020 Ext. 304

See original here:

Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines...

Read the Rest...

Nano Battery Market is Expected to Grow in 2021 by Top Companies- A123 Systems(Subsidiary of the Chinese Wanxiang Group), 3M, Front Edge Technology,…

§ January 5th, 2021 § Filed under Nanotechnology Comments Off on Nano Battery Market is Expected to Grow in 2021 by Top Companies- A123 Systems(Subsidiary of the Chinese Wanxiang Group), 3M, Front Edge Technology,…

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Nano Battery Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Nano Battery market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Nano Battery market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Nano Battery market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Nano Battery market.

Key questions answered in the report:


1 Nano Battery Market Overview 1.1 Nano Battery Product Overview 1.2 Nano Battery Market Segment by Type 1.2.1 Nano Phosphate Technology 1.2.2 Nanopore Battery Technology 1.2.3 Lithium-Ion Technology 1.3 Global Nano Battery Market Size by Type (2015-2026) 1.3.1 Global Nano Battery Market Size Overview by Type (2015-2026) 1.3.2 Global Nano Battery Historic Market Size Review by Type (2015-2020) Global Nano Battery Sales Market Share Breakdown by Type (2015-2020) Global Nano Battery Revenue Market Share Breakdown by Type (2015-2020) Global Nano Battery Average Selling Price (ASP) by Type (2015-2020) 1.3.3 Global Nano Battery Market Size Forecast by Type (2021-2026) Global Nano Battery Sales Market Share Breakdown by Type (2021-2026) Global Nano Battery Revenue Market Share Breakdown by Type (2021-2026) Global Nano Battery Average Selling Price (ASP) by Type (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Nano Battery Sales Breakdown by Type (2015-2020) 1.4.2 Europe Nano Battery Sales Breakdown by Type (2015-2020) 1.4.3 Asia-Pacific Nano Battery Sales Breakdown by Type (2015-2020) 1.4.4 Latin America Nano Battery Sales Breakdown by Type (2015-2020) 1.4.5 Middle East and Africa Nano Battery Sales Breakdown by Type (2015-2020) 2 Global Nano Battery Market Competition by Company 2.1 Global Top Players by Nano Battery Sales (2015-2020) 2.2 Global Top Players by Nano Battery Revenue (2015-2020) 2.3 Global Top Players Nano Battery Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Nano Battery Manufacturing Base Distribution, Sales Area, Product Type 2.5 Nano Battery Market Competitive Situation and Trends 2.5.1 Nano Battery Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Nano Battery Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Battery as of 2019) 2.7 Date of Key Manufacturers Enter into Nano Battery Market 2.8 Key Manufacturers Nano Battery Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Nano Battery by Region (2015-2026) 3.1 Global Nano Battery Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Nano Battery Market Size Market Share by Region (2015-2020) 3.2.1 Global Nano Battery Sales Market Share by Region (2015-2020) 3.2.2 Global Nano Battery Revenue Market Share by Region (2015-2020) 3.2.3 Global Nano Battery Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Nano Battery Market Size Market Share by Region (2021-2026) 3.3.1 Global Nano Battery Sales Market Share by Region (2021-2026) 3.3.2 Global Nano Battery Revenue Market Share by Region (2021-2026) 3.3.3 Global Nano Battery Sales, Revenue, Price and Gross Margin (2021-2026) 4 Global Nano Battery by Application 4.1 Nano Battery Segment by Application 4.1.1 Industrial 4.1.2 Military 4.1.3 Transport 4.1.4 Consumer Electronics 4.1.5 Renewable and Grid Energy 4.1.6 Others 4.2 Global Nano Battery Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Nano Battery Historic Sales by Application (2015-2020) 4.4 Global Nano Battery Forecasted Sales by Application (2021-2026) 4.5 Key Regions Nano Battery Market Size by Application 4.5.1 North America Nano Battery by Application 4.5.2 Europe Nano Battery by Application 4.5.3 Asia-Pacific Nano Battery by Application 4.5.4 Latin America Nano Battery by Application 4.5.5 Middle East and Africa Nano Battery by Application 5 North America Nano Battery Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Nano Battery Sales Market Share by Country (2015-2020) 5.1.2 North America Nano Battery Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Nano Battery Sales Market Share by Country (2021-2026) 5.2.2 North America Nano Battery Revenue Market Share by Country (2021-2026) 6 Europe Nano Battery Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Nano Battery Sales Market Share by Country (2015-2020) 6.1.2 Europe Nano Battery Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Nano Battery Sales Market Share by Country (2021-2026) 6.2.2 Europe Nano Battery Revenue Market Share by Country (2021-2026) 7 Asia-Pacific Nano Battery Market Size by Region (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Region (2015-2020) 7.1.1 Asia-Pacific Nano Battery Sales Market Share by Region (2015-2020) 7.1.2 Asia-Pacific Nano Battery Revenue Market Share by Region (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Region (2021-2026) 7.2.1 Asia-Pacific Nano Battery Sales Market Share by Region (2021-2026) 7.2.2 Asia-Pacific Nano Battery Revenue Market Share by Region (2021-2026) 8 Latin America Nano Battery Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Nano Battery Sales Market Share by Country (2015-2020) 8.1.2 Latin America Nano Battery Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Nano Battery Sales Market Share by Country (2021-2026) 8.2.2 Latin America Nano Battery Revenue Market Share by Country (2021-2026) 9 Middle East and Africa Nano Battery Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Nano Battery Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Nano Battery Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Nano Battery Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Nano Battery Revenue Market Share by Country (2021-2026) 10 Company Profiles and Key Figures in Nano Battery Business 10.1 A123 Systems(Subsidiary of the Chinese Wanxiang Group) 10.1.1 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Corporation Information 10.1.2 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Description, Business Overview 10.1.3 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.1.4 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Nano Battery Products Offered 10.1.5 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Recent Developments 10.2 3M 10.2.1 3M Corporation Information 10.2.2 3M Description, Business Overview 10.2.3 3M Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.2.4 A123 Systems(Subsidiary of the Chinese Wanxiang Group) Nano Battery Products Offered 10.2.5 3M Recent Developments 10.3 Front Edge Technology 10.3.1 Front Edge Technology Corporation Information 10.3.2 Front Edge Technology Description, Business Overview 10.3.3 Front Edge Technology Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Front Edge Technology Nano Battery Products Offered 10.3.5 Front Edge Technology Recent Developments 10.4 mPhase Technologies 10.4.1 mPhase Technologies Corporation Information 10.4.2 mPhase Technologies Description, Business Overview 10.4.3 mPhase Technologies Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.4.4 mPhase Technologies Nano Battery Products Offered 10.4.5 mPhase Technologies Recent Developments 10.5 Altair Nanotechnologies 10.5.1 Altair Nanotechnologies Corporation Information 10.5.2 Altair Nanotechnologies Description, Business Overview 10.5.3 Altair Nanotechnologies Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Altair Nanotechnologies Nano Battery Products Offered 10.5.5 Altair Nanotechnologies Recent Developments 10.6 Evonik Industries 10.6.1 Evonik Industries Corporation Information 10.6.2 Evonik Industries Description, Business Overview 10.6.3 Evonik Industries Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.6.4 Evonik Industries Nano Battery Products Offered 10.6.5 Evonik Industries Recent Developments 10.7 Sony 10.7.1 Sony Corporation Information 10.7.2 Sony Description, Business Overview 10.7.3 Sony Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.7.4 Sony Nano Battery Products Offered 10.7.5 Sony Recent Developments 10.8 Next Alternative 10.8.1 Next Alternative Corporation Information 10.8.2 Next Alternative Description, Business Overview 10.8.3 Next Alternative Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Next Alternative Nano Battery Products Offered 10.8.5 Next Alternative Recent Developments 10.9 Toshiba 10.9.1 Toshiba Corporation Information 10.9.2 Toshiba Description, Business Overview 10.9.3 Toshiba Nano Battery Sales, Revenue and Gross Margin (2015-2020) 10.9.4 Toshiba Nano Battery Products Offered 10.9.5 Toshiba Recent Developments 10.10 Sinlion Battery Tech 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Nano Battery Product Category, Application and Specification 10.10.3 Sinlion Battery Tech Nano Battery Sales, Revenue, Price and Gross Margin (2015-2020) 10.10.4 Main Business Overview 10.10.5 Sinlion Battery Tech Recent Developments 11 Nano Battery Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Nano Battery Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Nano Battery Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Nano Battery Industry Trends 11.4.2 Nano Battery Market Drivers 11.4.3 Nano Battery Market Challenges 11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read the original post:

Nano Battery Market is Expected to Grow in 2021 by Top Companies- A123 Systems(Subsidiary of the Chinese Wanxiang Group), 3M, Front Edge Technology,...

Read the Rest...

The Year Ahead: 3 Predictions From the ‘Father of the Internet’ Vint Cerf – Nextgov

§ January 5th, 2021 § Filed under Quantum Medicine Comments Off on The Year Ahead: 3 Predictions From the ‘Father of the Internet’ Vint Cerf – Nextgov

In 2011, the movie "Contagion" eerily predicted what a future world fighting a deadly pandemic would look like. In 2020, I, along with hundreds of thousands of people around the world, saw this Hollywood prediction play out by being diagnosed with COVID-19. It was a frightening year by any measure, as every person was impacted in unique ways.

Having been involved in the development of the Internet in the 1970s, Ive seen first-hand the impact of technology on peoples lives. We are now seeing another major milestone in our lifetimethe development of a COVID-19 vaccine.

What the"Contagion" didnt show is what happens after a vaccine is developed. Now, as we enter 2021, and with the first doses of a COVID-19 vaccine being administered, a return to normal feels within reach. But what will our return to normal look like really? Here are threepredictions for 2021.

1. Continuous and episodic Internet of Medical Things monitoring devices will prove popular for remote medical diagnosis. The COVID-19 pandemic has dramatically changed the practice of clinical medicine at least in the parts of the world where Internet access is widely available and at high enough speeds to support video conferencing. A video consult is often the only choice open to patients short of going to a hospital when outpatient care is insufficient. Video-medicine is unsatisfying in the absence of good clinical data (temperature, blood pressure, pulse for example). The consequence is that health monitoring and measurement devices are increasingly valued to support remote medical diagnosis.

My Prediction: While the COVID-19 pandemic persists into 2021, demand for remote monitoring and measurement will increase. In the long run, this will lead to periodic and continuous monitoring and alerting for a wide range of chronic medical conditions. Remote medicine and early warning health prediction will in turn help citizens save on health care costs and improve and further extend life expectancy.

2. Cities will (finally) adopt self-driving cars. Self-driving cars are anything but new, having emerged from a Defense Advanced Research Projects Agency Grand Challenge in 2004. Sixteen years later, many companies are competing to make this a reality but skeptics around this technology remain.

My Prediction: In the COVID-19 aftermath, I predict driverless car service will grow in 2021 as people will opt for rides that minimize exposure to drivers and self-clean after every passenger. More cities and states will embrace driverless technology to accommodate changing transportation and public transportation preferences.

3. A practical quantum computation will be demonstrated. In 2019, Google reported that it had demonstrated an important quantum supremacy milestone by showing a computation in minutes that would have taken a conventional computer thousands of years to complete. The computation, however, did not solve any particular practical problem.

My Prediction: In the intervening period, progress has been made and it seems likely that by 2021, we will see some serious application of quantum computing to solve one or more optimization problems in mechanical design, logistics scheduling or resource allocation that would be impractical with conventional supercomputing.

Despite the challenges 2020 presented, it also unlocked some opportunities like leapfrogging with tech adoption. My hope is that the public sector sustains the speed for innovation and development to unlock even greater advancements in the year ahead.

Vinton G. Cerf is vice president and chief Internet evangelist for Google. Cerf has held positions at MCI, the Corporation for National Research Initiatives, Stanford University, UCLA and IBM. Vint Cerf served as chairman of the board of the Internet Corporation for Assigned Names and Numbers (ICANN) and was founding president of the Internet Society. He served on the U.S. National Science Board from 2013-2018.

Excerpt from:

The Year Ahead: 3 Predictions From the 'Father of the Internet' Vint Cerf - Nextgov

Read the Rest...

Top research stories of 2020 | News – UCalgary News

§ January 5th, 2021 § Filed under Quantum Medicine Comments Off on Top research stories of 2020 | News – UCalgary News

Each year, we round up the most-read research stories based on Google analytics. Here are the top research stories of 2020.

An international research team, including UCalgary quantum physicists, has taken a big step toward building a high-performing, scalable quantum internet. A functional quantum internet would dramatically change the fields of secure communication, data storage, precision sensing and computing.The research team achieved sustained, long-distance teleportation, through 44 kilometres of optical fibre, of qubits of photons. The teleportation fidelity was greater than 90 per cent, using off-the-shelf equipment and state-of-the-art single photon detectors.Read more

A research team at theCumming School of Medicinehas made an exciting breakthrough with the potential to prevent and reverse the effects of Alzheimers disease.The team discovered that limiting the open time of a channel called the ryanodine receptor, which acts like a gateway to cells located in the heart and brain, reverses and prevents progression of Alzheimers disease in animal models. They also identified a drug that interrupts the disease process. The effect of giving the drug to animal models was remarkable: after one month of treatment, the memory loss and cognitive impairments in these models disappeared.Read more

After 50 years of research and the testing of more than 1,000 drugs, there is new hope for preserving brain cells for a time after stroke. Treating acute ischemic stroke patients with an experimental neuroprotective drug, combined with a surgical procedure to remove the clot, improves outcomes as shown by clinical trial results publishedinThe Lancet.Read more

Scientists at theHotchkiss Brain Institute(HBI),Alberta Childrens Hospital Research Institute(ACHRI), andOwerko Centreat UCalgarysCumming School of Medicinehave made a breakthrough discovery that could lead to treatment of Fragile X syndrome (FXS), the leading genetic cause of Autism Spectrum Disorder. The study, involving mouse models, shows promise of translating to treatment for people diagnosed with FXS.Read more

Researchers with theSnyder Institute for Chronic Diseasesat theCumming School of Medicine(CSM) have discovered which gut bacteria help our immune system battle cancerous tumours and how they do it. The discovery may provide a new understanding of why immunotherapy, a treatment for cancer that helps amplify the bodys immune response, works in some cases, but not others.Read more

Cats are notorious for hiding their pain. But despite this tendency to suffer in silence, the feline face speaks volumes about the pain its feeling. Veterinary researchers recently published a paper inScientific Reportson theFeline Grimace Scale, a fast, easy way of assessing a cats facial expressions to help determine how much pain it is feeling.Read more

Glioblastoma is the most aggressive form of brain cancer. Even with treatment, chemotherapy and radiation, most people die within 14 to 16 months of being diagnosed. One of the reasons this cancer is so deadly is because it hijacks the immune system,suppressing it and reprogramming immune cells to work for the tumour.A new study by members of theCumming School of Medicine(CSM) at theUniversity of Calgaryfinds niacin, commonly called vitamin B3, combined with chemotherapy can help immune cells attack glioblastoma, dramatically slowing progression of the disease, in mice.Read more

Paleontologists at the University of Calgary and Royal Tyrrell Museum have discovered a new large tyrannosaur from Alberta, a predatory dinosaur whose name means reaper of death. CalledThanatotheristes, the 79-million-year-old fossil is the oldest tyrannosaur known from northern North America and is the first new tyrannosaur species identified in Canada in 50 years, says the research teams study.Read more

A coronavirus test from the comfort of your living room, with results sent wirelessly from a hand-held biosensor to health officials, minutes after a sample is collected. Thats the latest COVID-19 research project from University of Calgary researchers and biomedical engineers, as they look to reduce in-person contact for people suspected ofbeing infected with SARS-CoV-2s, while increasing the efficiency and speed of testing for the virus at the root of the global pandemic.Read more

A research team led by scientists at theUniversity of CalgarysCumming School of Medicine(CSM) is sharing a new method to test for SARS-CoV-2, the virus that causes COVID-19. The test can provide results in 30 minutes without the need for high-tech equipment and the reagents that have been in limited supply worldwide.Read more

How did life begin?Its a question so fundamental that it's likely been pondered by every human who's ever lived. The originof life on ancient Earth is one of the oldest scientific mysteries. While researchers have been able to shed light on the subject over the years, the answers to sizeable questions about how Earths first organisms came to be remain couched in theory. An important new discovery byDr. Benjamin Tutolo, PhD, assistant professor in theDepartment of Geoscience, and co-authors Nicholas Tosca at theUniversity of Oxfordand Bill Seyfried at theUniversity of Minnesota, calls into question the leading theories behind the early days of earthly life with an unlikely catalyst the sea sponge.Read more

Excerpt from:

Top research stories of 2020 | News - UCalgary News

Read the Rest...

Need a boost for the new year? Pacific Northwest geeks share the different things that inspire them – GeekWire

§ January 5th, 2021 § Filed under Quantum Medicine Comments Off on Need a boost for the new year? Pacific Northwest geeks share the different things that inspire them – GeekWire

Need a little inspiration to make it out of 2020 and into 2021? Weve been asking data scientists, video game designers, engineers, doctors, students and startup founders all year where they find theirs.

Weve read more than enough about what has bummed us out over the past year. It might seem difficult to find something or someone that will make things look better or provide a motivating force in the coming months.

But our 2020 Geeks of the Week are inspired by the people they work with, the kids they care for, the stuff they read, the places theyve seen and much more.

Click the names of each to go back to the full Geek of the Week profile for that individual. And dont forget tofill out our questionnairein the new year if you want to be considered.

Keep reading for the answers to our weekly question, Where do you find your inspiration?

I hold the somewhat silly belief that true inspiration only comes from the subconscious, and dreams are the clearest window into it. I dont know about you, but I dont have a lot of product or engineering dreams though, so I have to work a little harder to find it.

Nothing beats finding people who are good at what they do, watching them do it, and thinking, Thats amazing. I bet I could do it better. This is really obvious for music (go to shows), but a little more difficult to emulate in a professional environment. Following smart people on LinkedIn/Twitter is a good start though.

I find inspiration in the people I work with every day not only at LevelTen, where folks have dedicated themselves to making renewable energy investment more efficient and impactful, but also the project developers who are the boots-on-the-ground building wind and solar projects across the globe. I love the days when a developer will send us photos of one of our clients projects in-construction. Knowing that we played a part in getting the wind or solar project built is one of the best feelings.

Education is a long game. Sometimes we never know or see the impacts of our work. But if you stay in the field long enough, youll often hear from former students or teachers who share with you how your efforts made a difference. Thats the best feeling in the world to be able to be of service to someone else as they find their own path in life.

When I was a high school teacher in the 1990s, I participated in the Fred Hutch teacher program I now direct (the Science Education Partnership, SEP). The program was transformative for my own career so Im delighted to be able to help other teachers have similar experiences.

Our greatest gifts, teachers, and access to a fuller life, consistently lives beyond what is comfortable. Finding comfort within discomfort is a muscle that can be cultivated, but we can also dive right in. Either way, not only will we be OK, well thrive and feel so much more alive.

I find inspiration everywhere. I love looking at data science articles about cross industry and cross field applications. The hardest skill to learn or have as a data scientist is creativity. By staying active and following podcasts, reading, and learning new skills you help to build your creativity through mental flexibility.

I come up with a lot of ideas on flights. I have a difficult time reading or watching movies without getting motion sickness and my brain kicks into overdrive due a false positive signal of being in danger. Unable to sleep, or consume media, all thats left to do is take stock of my current position and consider possible paths forward.

In my free time, when the weather allows, I hike. Hiking is a great reminder that were all capable of accomplishing daunting feats. When I do feel overwhelmed with the tasks Ive set before myself, I remind myself how far my legs can carry me. Even if its hard, even if I must stop and breathe, I can accomplish my goals if I just put one foot in front of the other.

I dont really know if there is a single source of inspiration. It can come from many sources: my colleagues, our customers, or my family. At times, I am inspired because I notice an opportunity where a scientific solution can have a long-term impact. At other times, I am seized by a complex problem where I know we need a better solution.

The journey of learning and discovery when creating things or thinking about creating things keeps me inspired. Even more so, having friends across the creative spectrum, making things from exotic furniture to category-defining software keeps me motivated to do my best work.

Seeing the impact that I can have making somebodys day better, or taking something off their plate so they can focus on their job. I put a lot into my job but I get so much more back from seeing the value that I bring in helping people, being positive.

Im inspired by the notion that if nothing is done, and if its not done fast, we wont have much to pass on to the next generation. That everything we do today has an effect tomorrow and how we drastically need to improve what we do today.

I am surrounded by interesting and beautiful people in my life and my work. Their ideas, good will, kindness and generosity inspire me every day.

For my 16th birthday, my dad bought me a 6-pack of Tony Robbins CDs, so I suppose I started there. In college, I loved to learn about how PNW leaders built their careers and their companies so Id watch documentaries or read biographies on folks like Bill Gates or Howard Schultz. As Ive gotten older, however, I realize now that my early inspiration truly did come from my parents, as it does for most.

I actually remember as a young girl going to my moms office with her and Id sleep under her desk as she worked late. I didnt mind, I loved watching her in her element while I colored and would sneak into the presidents corner office to spin in his chair, dreaming.

And now, I draw so much energy from the folks who choose to work with Lions+Tigers. Im just in awe of their work, their energy and what they bring to our community. It makes everything so fulfilling.

Helping to develop technologies that will either take advantage of resources off-planet and therefore give Earth some relief, or that will help us treat our planet better is my vocation.

There are a lot of people on Earth, and we along with all the trillions of organisms with which we coexist are beginning to give our biosphere some significant growing pains. If we want to exist for another thousand (let alone another hundred) years we need to look outward for resources, space (no pun intended), and knowledge.

Finally, the poetic nature of working with technologies that are operating where only a choice few humans have gone before is exciting to me. Its humbling and empowering to be able to say, I tell satellites what to do!'

It may sound clich, but I really am inspired by how incredible our world is and of course, especially sea ice and the ocean. A small example: did you know flowers can grow on sea ice? Okay, theyre not normal flowers, but under certain conditions sea ice can form what are called frost flowers. They are beautiful, delicate structures made of ice filaments, and super salty. There are so many little things to get excited about.

Many places. But here are two: My brother Hayden, who spins poi balls, which is a flow art. Hes three years younger than I am and he started going to spin jams and flow festivals (think mini-Burning Man) and spinning fire when he was only 9 years old. There was no one else there his age. By doing this he showed me that it would also be possible for me to fit into a community of mostly adults. This inspired me and gave me the confidence to start going to hackathons and doing that has created so many opportunities for me.

Also, Marcus Yallow (a.k.a. w1n5t0n), the high-school-aged hacker from the books Little Brother and Homeland by Cory Doctorow.

My inspiration comes from the gap between what is and what can be. Its one of the most important things that I picked up from Bill and Melinda Gates during the time that I worked at the Gates Foundation. Technology is necessary but not sufficient for bridging that gap. And that leads right back to why I do what I do at WRF!

Sharing ideas with friends and colleagues, as well as my mementos.

If youre asking me, where do I find inspiration for the work that we do, I love observing and watching other industry. My favorites are grocery stores, department stores, and airports and hotels. I look to see how people are treating their customers, and if youre treating your customers well, they will love your product. That is where I get my inspiration for what our library is going to do and where were going to go.

Much of my inspiration comes from our customers and contributors and seeing the impact of the work we do at Microsoft Quantum. One of my favorite and most motivating moments so far on the Quantum team was spending time with attendees at last years Microsoft Ignite conference. For many it was the first time they were learning about quantum computing, and seeing their excitement and curiosity was incredibly energizing. I learned recently that we had a high school student contribute to our open source Quantum Katas (designed to teach quantum computing & the Q# programming language), and that they were so excited to be able to be able to contribute and get involved in quantum computing without an advanced degree. I cant help but smile and feel inspired by stories like that.

I love modern Japanese culture. I love how they understand so well their own culture that they can create new pieces of art or media that fit within their own vision of the world, but its completely new. You can instantly identify a Japanese game by just looking at a screen shot, even if it doesnt contain traditional Japanese culture, you see the influence of it. I want to do the same thing with my own culture, use it as input and create a completely new thing that the world hasnt seen before but it could only be created through a Mexican lens.

My father. His personal journey and sacrifice to come to the United States with basically nothing is the classic immigrant American dream story. But as a relatively new father I see things through a different lens. The opportunity he has afforded me and my family with his sacrifices is truly pressure to continue to achieve more in his honor.

Building small robots and sensors is hard, and in many cases nature does a much better job. For example a bee can fly around for hours longer than drones we can build. It certainly helps that evolution has a few million years head start on us, so lately Ive been thinking a lot about what we can learn from natural systems and about ways we can piggyback on their abilities to achieve things we couldnt otherwise build.

I search for moments of beauty in the world around me. The color of a leaf, the curve of a bone, the texture of a concrete wall, the lines of a building. I find these moments in nature, in the work of other artists, or even just walking down the street. When I find something that strikes me as beautiful, I seek to understand why I respond to it. What about this object, scene, or space is captivating? I then try to emulate these moments in my work, string them together to form a story, forge them into one cohesive whole that is more than the sum of its parts.

I love war stories and the extraordinary people who work in their studies pouring over research, scout the streets for information, and crawl in the trenches fighting to defend their country or cause.

The best business consultant Ive ever had is my 9-year-old daughter, Kira. Shes the one who first suggested this idea!

In all seriousness, the best ideas come to me when I travel. There are very few new ideas these days. But seeing how others are doing things and figuring out how to do it better, can often produce remarkable results.

The kids, always. I am frequently reminded of why I do the work I do when I think of the many children and their families I cared for as a pediatric oncologist.

I often think of one little boy who had leukemia, but as part of his treatment required radiation of his brain and spine. His mom who is so grateful he survived once told me that she saw the light go out of his eyes after that treatment.

The thought of the damage that our cures create is unacceptable. Weve got to do better.

Meet Rose, an adorable 70-year-old woman who was ready to retire. Rose was a teacher, diligently saving for her retirement for over 30 years, putting away every hard-earned penny she could. Except for one problem: Rose had never actually INVESTED that money. Rose had deposited money into an account but had never chosen her investments. She didnt know she needed to. Her money was in financial purgatory earning no interest, sitting there for 30 years, and never growing one bit. Rose could no longer afford to retire because she did not have enough money to sustain herself. I cry every time I think about her. She is my fuel. Every day since I heard her story, my life has been in service of womens financial education. I want to prevent women from having the same experience as Rose.

My inspiration comes from everywhere: talking with my friends, trying to find a new cafe, browsing at the local antique stores, art shows, poems, movies, games, and Twitch streaming. I try to have new things in my life as much as possible. I hope I finish making Pandemic soon so I can begin traveling again!

The ability to positively impact people at scale, especially in education, charges my engines. Especially in the space of assistive technology and accessibility, there is so much opportunity to help so many people. Because Microsoft is a company with global reach, amplifying that impact is about as motivating as it gets for me.

I decided to go to grad school to study fluid dynamics after seeing the vortical patterns in a bowl of miso soup and realizing that it was more interesting than what I was working on.

But seriously, mostly in my students and collaborators, who help me blur the line between work and play.

In my many friends and colleagues who pour their energy into creating a better future for everyone. Some are great activists/organizers, mentors/teachers, public science communicators, or brilliant scientists. They are willing to put themselves forward in one way or another. Theyve cemented for me the notion that we all have some role to play, big or small, whether out in front or behind the scenes, towards handling climate change.

Social media, mostly. I primarily use the programming language R for doing data science and there is a welcoming and vibrant community of R users on Twitter. I also follow a lot of artists on instagram and thats a great place to draw inspiration for my art.

Exercise clears my mind and the most creative moments of inspiration usually follow. Recently I was e-mountain biking in Alaska and suddenly it dawned on me that incorporating our focus on cybersecurity as a key competitive differentiator could make a positive impact on our prospecting and lead generation.

Read more:

Need a boost for the new year? Pacific Northwest geeks share the different things that inspire them - GeekWire

Read the Rest...

Four Reasons Why 2020 Was The Year Of The HBCU – Forbes

§ January 5th, 2021 § Filed under Quantum Medicine Comments Off on Four Reasons Why 2020 Was The Year Of The HBCU – Forbes

Cheyney University in Cheyney, Pa., was the nation's first HBCU, established in 1837. (AP Photo/Matt ... [+] Rourke)

Much of higher educations 2020 news ranged from the discouraging to the alarming - a raging pandemic, sinking enrollments, decimated budgets, unhappy students, exhausted faculty and administrators, and a growing public disillusionment about the value of college.

Against this backdrop, however, one higher education sector attracted renewed interest amid signs of a welcomed renaissance. Indeed, 2020 was a banner year for Americas historically black colleges and universities(HBCUs), the approximately 100 public and private institutions established primarily to serve theAfrican American community.

According to theHigher Education Act of 1965, an HBCUis: any historically black college or university that was established prior to 1964, whose principal mission was, and is, the education of black Americans, and that is accredited by a nationally recognized accrediting agency or association determined by the Secretary [of Education] to be a reliable authority as to the quality of training offered or is, according to such an agency or association, making reasonable progress toward accreditation.

HBCUs pave a broad avenue of access to postsecondary education, and not only for Black students. They also serve a significant proportion of first-generation students and those from low-income families. And theyve become an increasingly popular destination for international students.

According to the American Council on Education, while HBCUs represent just 3% of institutions eligible for federal student financial aid, they award 17% of all bachelors degrees earned by Black students. With an overall enrollment of about 300,000, HBCUs also play a major role in graduating Black students with bachelors degrees in STEM fields.

HBCUs have long battled strong headwinds. They are chronically underfunded compared to other public institutions. Their endowments are smaller than most private schools. And like many colleges, they are grappling with declining enrollments. Because most HBCUs are small, they typically have little cushion to absorb decreased revenue.

But 2020 saw HBCUs receive increasing and much-deserved support. Policy makers paid more attention to their missions, social issues raised awareness about their importance, noteworthy alums captured national headlines, and several historical firsts were achieved.

Here are four reasons why 2020 will be remembered as a noteworthy year for HBCUs.

The Presidential Election

One indication of HBCUs renaissance was the attention they garnered from presidential candidates, particularly among the Democrat contenders. All of the most prominent Democrats seeking their partys nomination - Joe Biden, Mike Bloomberg, Pete Buttigieg, Amy Klobuchar Bernie Sanders, and Elizabeth Warren - proposed substantial funding boosts for HBCUs as part of their educational platforms.

Even Donald Trump, whose advocacy for HBCUs appeared largely symbolic, via Executive Orders and proclamations, offered some support. Late in 2019 he signed the Futures Act, a rare triumph of congressional bipartisanship that permanently provided more than $250 million annually to the nations HBCUs along with other institutions serving large numbers of minority students.

Joe Biden has pledged he will invest significantly in HBCUs and other minority-serving institutions and has publicized plans for spending more than $70 billion on various initiatives at these schools.

The Racial Justice Movement

The killing of George Floyd and several other Black citizens at the hands of the police led to demonstrations by millions of Americans throughout the summer. In fact, the various marches and demonstrations may have beenthe largest protest movement in the countrys history.

Much of that activity was inspired by Black Lives Matter (BLM), which recently has seen a resurgence in public support. College athletes picked up the BLM mantle and began speaking out against racial injustice and police brutality.

Following the athletes lead, more college students got off the sidelines and joined the action.They aimed their anger at convenient campus targets. Whether it wasPrincetonremoving Woodrow Wilsons name from its public policy school,Washington and Lee facultyvoting to drop Lee from the universitys name, or tearing down Confederate symbols at theUniversity of Mississippi, colleges and universities found a sudden willingness to distance themselves from relics of a racist past.

The dramatic increase in racial awareness is anticipated to usher in a Floyd Effect, an increase in applications to HBCUs by Black students who want the safety and security they feel is missing at many predominantly white universities. Its something akin to the Missouri Effect, the uptick in applicants to HBCUs that followed racial tensions at the University of Missouri several years ago.

Greater awareness of racial injustices and the importance of increasing educational opportunities for Black Americans also led to new interest by wealthy Americans in HBCUs and other colleges serving large numbers of first-generation, minority, and low-income students.

A Record-Shattering Year of Private Gifts

Dozens of HBCUs received multi-million-dollar donations in 2020, taking some of the spotlight away from the elite colleges that typically garner most of higher educations mega-gifts.

Leading the list were MacKenzie Scotts two tranches of donations to hundreds of organizations, totaling about six billion dollars. HBCUs received over $500 million from Ms. Scott, largely unrestricted in nature, with most of the individual gifts in the $15 to $50 million range.

But Ms. Scotts gifts were not the end.

A Year 0f Historical Firsts

Several HBCUs achieved new milestones this year. Start with the obvious fact that a number of the years major political figures were HBCU alums.

HBCUs took major strides in STEM education in 2020.

Other firsts:


HBCUs were by no means immune to the travails of 2020. The pandemic increased their financial struggles, and it hit communities of color particularly hard. However, collectively HBCUs earned a much higher profile on the higher education landscape. Their presidents demonstrated steady leadership during the pandemic, the accompanying economic troubles, and multiple episodes of racial turmoil. Their alumni, missions and academic programs attracted record philanthropy. And now they stand poised to become an even greater national asset with a new administration in Washington, D.C. thats committed to their purpose and possibilities.

More here:

Four Reasons Why 2020 Was The Year Of The HBCU - Forbes

Read the Rest...

« Older Entries Newer Entries »

Page 3«..2345..1020..»